Contact

Department

Cellular and Integrative Physiology

Somayyeh Nasiripour, Ph.D.

Postdoctoral Fellow

Lab Association: Jean C. Bopassa, PhD

Personal Statement:

Dr. Nasiripour was assistant professor of clinical pharmacy at Iran university of medical Sciences (IUMS) from 2014 to 2023. she has 10 years’ experience in teaching medical students and running some clinical trials. She did some clinical trials in the field of cardiology in the journal with high impact factor.

She completed her clinical pharmacy PhD at Tehran University of medical Sciences (TUMS) in May 2013 and graduated with taking second place in the Board of pharmacotherapy exam.  She did thesis with the title” Comparison of the Effects of Enoxaparin and Heparin on Inflammatory Biomarkers in Patients with ST-segment Elevated Myocardial Infarction: A prospective Open Label Pilot Clinical Trial”, published in Iranian Journal of Pharmaceutical Research (IJPR) in 2014.

After moving to San Antonio, Dr. Nasiripour joined Dr. Bopassa as a postdoctoral fellow.

Education

Clinical Pharmacy, PhD, College of Pharmacy, Tehran University of Medical Sciences; Tehran Iran 2006-2013

Awards & Accomplishments

  • Educational system award for top ranked student in Residency University Entrance Exam (2005)
  • Educational Student Scholarship, Iranian Ministry of Health
    Residency of Pharmacotherapy Program, Tehran university of medical sciences (2006-2013)
  • Ranked second in a board of pharmacotherapy competition (2010)
  • Top lecturer among lecturer in community pharmacy unit (2011)
  • First rank among participants in the Comprehensive Exam of Bulletin of 13 Aban Pharmaceuticals Center on March 7, 2014

Publications

  1. A comparative study to assess the effectiveness of curcumin, mucosamin, and chlorhexidine in chemotherapy-induced oral mucositis. F Fardad, K Ghasemi, N Ansarinejad, N Khodakarim, S Nasiripour et al. Explore 2023; 19 (1), 65-70
  2. An Open‐Label, Single‐Arm, Pilot Intervention Study to Assess the Efficacy and Safety of Apixaban in Heparin‐Induced Thrombocytopenia. M Farasatinasab, S Balouchzehi, OM Moghaddam, N Ansarinejad S Nasiripour(corresponding author). The Journal of Clinical Pharmacology 2022; 62 (11), 1379-13843. Cerebral Venous Sinus Thrombosis in a Young Body Builder Man With Androgen Use. M Farasatinasab, OM Moghaddam, S Nasiripour, M Hosseinzadeh Emam. Annals of Pharmacotherapy,2022; 56(9) 1079-10814. Effect of cannabis use on propofol requirement for ICU sedation. M Farasatinasab, S Nasiripour, A Aghabiklooei. Anaesthesiology Intensive Therapy 2022; 54 (1)5. MicroRNAs and SARS-CoV-2 life cycle, pathogenesis, and mutations: biomarkers or therapeutic agents? F Abedi, R Rezaee, AW Hayes, S Nasiripour, G Karimi. Cell Cycle 2021; 20 (2),143- 1536. Rivaroxaban as an alternative agent for heparin‐induced thrombocytopenia. M Farasatinasab, B Zarei, M Moghtadaei, S Nasiripour(corresponding author)., N Ansarinejad. The Journal of Clinical Pharmacology 2020; 60 (10), 1362-1366

    7. Can Colchicine as an Old Anti‐Inflammatory Agent Be Effective in COVID‐19?. M Farasatinasab, S Nasiripour,F Zamani. The Journal of Clinical Pharmacology 2020 ; 60(7): 828–829.

    8. Preparation and evaluation of oxytocin SLNs as semi-finished product for nasal drops formulation. SM Alavi, S Ghaffari, S Nasiripour. Medical Science Journal of Islamic Azad University2020; 30 (1)

    9. Beneficial effects of oral lactobacillus on pain severity in women suffering from endometriosis: A pilot placebo-controlled randomized clinical trial. S Khodaverdi, R Mohammadbeigi, M Khaledi, L Mesdaghinia, S Nasiripour. International Journal of Fertility & Sterility 2019; 13 (3), 178

    10. Rituximab utilization evaluation with focused on available evidence for off-labeled indications. M Farasatinasab, S Aghabeigi, S Ramezaninejad, A Amouzegar, S Nasiripour. Journal of Pharmaceutical Care,2019; 14-20

    11. Methotrexate infusion followed by uterine artery embolisation for the management of placental adhesive disorders: a case series. MR Babaei, MO Kian, Z Naderi, S Khodaverdi, Z Raoofi, F Javanmanesh, S Nasiripour. Clinical Radiology 2019; 74 (5), 378-383

    12. Dabigatran as a treatment option for heparin‐induced thrombocytopenia. S Nasiripour, M Saif, M Farasatinasab, S Emami, A Amouzegar, A Basi. The Journal of Clinical Pharmacology 2019; 59 (1), 107-111

    13. A case of ciprofloxacin-associated Achilles tendinitis. V Pirhajati Mahabadi, S Nasiripour, M Farasatinasab, S Nadjafi. Physiology and Pharmacology 2017; 21 (3), 172-174

    14. A double blind randomized trial of efficacy and safety of 5% methimazole versus 2%hydroquinone in patients with melasma. N Atefi, E Behrangi, S Nasiripour, G Mehran, S Naeji, M Azizi, P Hassani,. Journal of Skin and Stem Cell 2017; 4 (2)

    15. Neuroprotective Effects of Stiripentol on Oxygen-Glucose Deprivation in Primary Culture of Fetal Mice Cortical Neurons. N Fotovat Eskandari, G Vahabzadeh, F Golab, F Karimzadeh, S Nasiripour. The Neuroscience Journal of Shefaye Khatam 2017; 5 (1), 10-17

    16. Premature Ejaculation Management. S Nasiripour, M Farasatinasab. Razi Journal of Medical Sciences 2017;23 (152), 65-76

    17. The content of plasma selenium in early admitted septic patients. OM Moghaddam, MN Lahiji, A Moghaddas, M Farasatinasab, S Nasiripour. Journal of Research in Pharmacy Practice 2017;6 (1), 52

    18. Drug-drug interactions: the importance of medication reconciliation. MJ Makiani, S Nasiripour, M Hosseini, A Mahbubi. Journal of research in pharmacy practice 2017; 6 (1), 61

    19. Breast cancer epigenetics. B Abbasi, NA Nejad, F Fardad, S Nasiripour, T Ramim. Tehran University Medical Journal 2016; 74 (8), 535-544

    20. Evaluation of Antimicrobial Susceptibility of Gram Negative Organisms by Minimum Inhibitory Concentration Method in Bandar Abbas, South of Iran. MJ Makiani, M Farasatinasab, S Nasiripour. Journal of Pharmaceutical Care, 2016; 40-43

    21. Management of abnormal placenta implantation with methotrexate: a review of published data. M Farasatinasab, A Moghaddas, S Dashti-Khadivaki, Z Raoofi ,S Nasiripour. Gynecologic and Obstetric Investigation 2016; 81 (6), 481-496

    22. Comparison of the Effects of Enoxaparin and Heparin on Inflammatory Biomarkers in Patients with ST-segment Elevated Myocardial Infarction: A prospective Open Label Pilot Clinical Trial. S Nasiripour, S Mousavi, A Mohagheghi, M Radfar, M Abdollahi. Iranian Journal of Pharmaceutical Research: IJPR 2014; 13 (2), 583

    23. The effect of educating the use of spray by visual concept mapping method on the quality of life of children with asthma. P Bozorgzad, A Ebadi, M Moin, F Sarhangy, S Nasiripour, MA Soleimani, Iranian Journal of Allergy, Asthma and Immunology, 2013; 63-67

    24. Intra-articular hyaluronic acid injections Vs. dextrose prolotherapy in the treatment of osteoarthritic knee pain. SM Hashemi, F Madadi, S Razavi, M Nikooseresht, FH Kiyabi, S Nasiripour. Tehran University Medical Journal 2010; 70 (2)

    25. Approach to Pandemic 2009 influenza: first report from a main referral hospital for Pandemic H1N1 influenza care in Iran . S Dashti-Khavidaki, H Khalili, F Gholamalipour, A Soudbakhsh, S Nasiripour. The Journal of Infection in Developing Countries 2010; 4 (10), 629-635

    26. Gastric healing effect of melatonin against different gastroinvasive agents in cholestatic rats. Moezi L1, Nasiripoor S, Mohajer V, Maghsoodi M, Samini M. Pathophysiology 2010; 17 (1), 65-70

    27. Serum vitamin D concentration in pandemic 2009 H1N1 influenza infected patients. H Khalili, S Nasiripour, M Etminiani-Esfahani. Journal of Diabetes and Metabolic Disorders 2010; 9, 19